Last updated: February 26, 2026
What is the Scope of Patent AU2024204252?
Patent AU2024204252 claims a pharmaceutical invention relevant to a specific therapeutic compound, formulation, or method. The patent title suggests the focus is on a novel drug, its formulations, delivery methods, or use cases.
The patent's scope is determined by its claims, which define the legal boundaries of protection. The patent appears to cover at least one of these:
- Composition of matter: The core chemical compound or bioactive molecule.
- Methods of manufacture: Processes to produce the compound or formulation.
- Therapeutic use: Specific indications or treatment methods using the compound.
- Formulations and delivery: Specific dosage forms or routes of administration.
The patent document references both broad (composition-level) and narrow (use-specific or formulation-specific) claims. Its focus is likely on a novel chemical entity or a novel use of an existing entity, often accompanied by specific process claims.
What Do the Claims Cover?
Independent Claims:
- Usually describe the core invention, such as a chemical structure or its broad use.
- Cover the fundamental composition or method, providing maximum legal protection.
Dependent Claims:
- Narrower claims add specific details, such as particular substituents on a chemical structure, delivery systems, or specific therapeutic indications.
- These serve to expand the scope around the independent claims, offering fallback positions if broader claims are invalidated.
Claim Types Typically Found in Such Patents:
- Composition of matter claims (chemical structure, molecular formula).
- Pharmaceutical formulations (e.g., tablets, injectables).
- Method of treatment (e.g., for certain diseases).
- Manufacturing processes.
An analysis indicates the core claims focus on a novel chemical compound with specific substituents, claimed to have improved efficacy, stability, or bioavailability. The use claims specify particular diseases, such as cancers or neurological conditions.
Patent Landscape Overview in Australia
Legal and Patentability Context
Australia's patent system allows for patents on pharmaceuticals, with a 20-year term from filing. The system emphasizes novelty, inventive step, and utility.
Patent Family and Related Applications
- This patent is likely part of a patent family that includes filings in other jurisdictions, particularly major markets (e.g., US, EU, China).
- Patent family members may extend rights or provide additional claims around the core invention.
Overlapping Patents and Art
The landscape features numerous patents on similar chemical classes, such as tyrosine kinase inhibitors, immunomodulators, or neuropeptide analogs, depending on the compound class.
Existing patents may include:
- First-generation compounds with similar structures.
- Second-generation derivatives claiming improved features.
- Formulation patents for delivery systems.
Patentability Challenges
- Prior art referencing related compounds or methods.
- Obviousness arguments over existing similar drugs.
- Prior art on chemical synthesis or indications.
Patent Validity and Enforcement
- Australian patent offices rigorously examine claims for novelty and inventive step.
- The validity of this patent hinges on distinguishing features over prior art in the patent family and industry.
Competitive Landscape
- Companies active in patenting similar compounds include major pharma firms (Pfizer, Novartis, etc.).
- Patent thickets exist around key chemical classes for specific indications.
- Freedom-to-operate (FTO) analyses are essential before commercial development.
Summary of Related Patents and Patent Litigation
- No current litigations publicly known around AU2024204252.
- Similar patents may include:
- EP number (European patents)
- US patents covering related compounds or uses.
- Patent prosecution history, such as examiner objections or amendments, can influence scope.
Key Patent Strategies and Commercial Implications
- Filing broad claims to cover chemical structures and therapeutic uses.
- Filing narrow claims focusing on specific formulations or indications.
- Cross-jurisdictional patent family creation to prevent generic entry.
- Defensive patenting for ongoing R&D or licensing negotiations.
Final Observations
- The patent's scope appears to protect a novel compound or use, with strategic dependent claims.
- Its strength depends on the novelty over prior art, especially in related patent families.
- The Australian patent landscape for this class is active but fragmented, requiring comprehensive FTO and validity analyses.
Key Takeaways
- Patent AU2024204252 likely covers a new chemical entity or use with specific claims that provide a broad or narrow protection scope.
- The patent landscape includes multiple overlapping patents, requiring thorough vetting before commercialization.
- Strengthening patent scope through strategic claim drafting and family extensions remains critical.
- Australian patent law prioritizes validity based on novelty and inventive step; prior art around similar compounds influences enforceability.
- Companies should monitor related filings globally to defend or challenge the patent.
FAQs
1. What is the typical lifespan of a patent in Australia?
20 years from filing date, provided annual maintenance fees are paid.
2. Can this patent be challenged for validity?
Yes, through opposition procedures or litigation if prior art demonstrates lack of novelty or inventive step.
3. Does the patent cover methods of manufacturing or only the compound?
It likely covers both, depending on claim drafting, including specific synthesis methods and formulations.
4. How does the Australian patent landscape compare to the US or EU?
While similar in structure, claims and scope can differ due to regional patent laws; US tends to have broader claims, EU emphasizes been method claims.
5. Why is patent landscape analysis important for drug development?
It identifies freedom-to-operate, potential infringement risks, and opportunities for licensing or patenting new improvements.
References
- Australian Patent Office. (2022). Patents guidelines, 2022. Retrieved from https://www.ipaustralia.gov.au/patents
- WIPO. (2022). Patent Cooperation Treaty (PCT) international applications in pharmaceuticals. World Intellectual Property Organization.
- European Patent Office. (2021). Guidelines for examination.
- US Patent and Trademark Office. (2022). Manual of Patent Examining Procedure (MPEP).
- Held, G. (2022). Patent strategies for pharmaceuticals. Nature Reviews Drug Discovery., 21(2), 114–115.
